A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
Clinical trial NCT05731128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05731128
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2026-05-13
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.